Welcome - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Search Results Your Search for 'Revolutionise Drug Discovery through Genomics and Proteomics Study' returned 3 results - Page 1 of 1  FEATURED RESULTS Cell Therapy - Technologies, Markets and Companies Gene Therapy - Technologies, Markets and Companies Cytogenetics - Technologies, Markets and Companies Personalized Medicine - Scientific and Commercial Aspects RNAi - Technologies, Markets and Companies   Sort by    Date Published ASC Date Published DESC Report Price ASC Report Price DESC Rank ASC Rank DESC   Sorted by Rank Top-Bottom Overview of the European Drug Discovery Market   Frost & Sullivan, Dec 2008, Pages: 98 revolutionised the process of drug discovery. Today, the collaborative contribution of genomics, proteomics, combinatorial chemistry and bioinformatics allows for rapid and precise discovery of the respective The Role of Nanotechnology in European Drug Discovery   Frost & Sullivan, May 2006 chemistries. However, the genomics and proteomics revolution has resulted in the delivery of massive amounts of data related to molecular components, thus providing the drug discovery industry with a greater Cancer, CNS & Cardiovascular Biomarkers: Players, products and prospects   Espicom Business Intelligence Ltd, Aug 2008, Pages: 352 genetic and proteomic components of the disease. It has been the focus for the majority of the early biomarker research which was aimed at the discovery and identification of biomarkers that guided Results:  First -   Prev -   1 -   Next -   Last

		For enquiries please call us on:   +353-1-415-1241 (GMT Office Hours)   1-800-526-8630 (US/Canada Toll Free)   1-917-300-0470 (EST Office Hours)

All rights reserved. © Copyright 2012 Research and Markets3    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network